Unknown NA INTERVENTIONAL 1-arm NCT05273333

Effect of Ultra-gyn® on Vulvovaginal Candidiasis

Sponsor: Biocodex

Conditions Vulvovaginal Candidiasis, Genital

Interventions Ultra-gyn®

Updated 4 times since 2022 Last updated: Mar 9, 2022 Started: Feb 23, 2022 Primary completion: Jul 31, 2022 Completion: Dec 31, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05273333, this NA trial focuses on Vulvovaginal Candidiasis, Genital and remains ongoing. Sponsored by Biocodex, it has been updated 4 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Apr 2024 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Apr 2022 — Apr 2024 [monthly]

Recruiting NA

First recorded

Feb 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Biocodex

Data source: Biocodex

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Quatre Bornes, Mauritius